Skip to content

comparison of Letrozole and Clomiphene in combined regimens with gonadotropins in pregnancy rate in pcos patients with clomiphene resistant polycystic ovarian syndrome.

comparison of Letrozole and Clomiphene in combined regimens with gonadotropins in pregnancy rate in pcos patients with clomiphene resistant polycystic ovarian syndrome.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138810132967N1
Enrollment
120
Registered
2010-02-27
Start date
2007-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clomiphene resistant polycystic ovarian syndrome. Noninflammatory disorders of female genital tract

Interventions

Intervention 1: Letrozole 5mg (2 tablets) orally from 3-7 days of menstrual cycle in addition to gonadotropine (HMG) ampule 5th to 9th days of menstrual cycle which was continued on tenth or eleventh
Treatment - Drugs
Letrozole 5mg (2 tablets) orally from 3-7 days of menstrual cycle in addition to gonadotropine (HMG) ampule 5th to 9th days of menstrual cycle which was continued on tenth or eleventh day of cycle af
Clomiphene 100mg (2 tablets) from 3-7 days of menstrual cycle in addition to gonadotropine (HMG) ampule 5th to 9th days of menstrual cycle which was continued on tenth or eleventh day of cycle after t

Sponsors

Vice-chancellor for Research, Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Clomiphene resistant polycystic ovarian syndrome, age 20-35 years Exclusion criteria: BMI more than 27, presence of hypothyroidism, hyperprolactinemia, or decreased ovarian reserve, male factor infertility, tubal or uterine factor diagnosed by HSG, peritoneal factor (history of previous surgery)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Endometrial thickness. Timepoint: Tenth or eleventh day of menstrual cycle. Method of measurement: Transvaginal sonography.;Ovarian response. Timepoint: Tenth or eleventh of menstrual cycle. Method of measurement: Transvaginal sonography.

Secondary

MeasureTime frame
Gonadotropin ampule consuption. Timepoint: Tenth or eleventh of menstrual cycle. Method of measurement: Transvaginal sonography.;Pregnancy rate. Timepoint: Two weeks after HCG injection. Method of measurement: pregnancy test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Fatemeh Foroozanfard

Kashan University of Medical Sciences

forozanfar_f@kaums.ac.irfatemehforoozanfard@yahoo.com+98 36 1542 1355

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026